Neogen Corporation — Form 10-Q Summary
Business context and reporting period. The filing covers the three months ended August 31, 2023, Neogen’s first quarter of fiscal 2024. Neogen develops and sells food-safety and animal-safety products and services. Results include the 3M Food Safety Division (FSD), acquired September 1, 2022, making reported year-over-year growth substantially acquisition-driven.
Financial results
| Metric | Quarter ended Aug. 31, 2023 | Prior-year quarter |
|---|---|---|
| Revenue | $229.0 million | $132.3 million |
| Gross profit / margin | $116.8 million / 51.0% | $62.3 million / 47.0% |
| Operating income / margin | $19.1 million / 8.4% | $6.1 million / 4.6% |
| Net income | $1.5 million | $5.2 million |
| Diluted earnings per share | $0.01 | $0.05 |
| Operating cash flow | $23.0 million | $(14.1) million |
- Revenue and segments: Revenue increased 73%; Food Safety revenue rose 157% to $166.3 million, including $98.0 million from 3M FSD. Animal Safety revenue fell 7% to $62.7 million. Management reported consolidated core sales growth of negative 1%, excluding specified acquisition, currency, and discontinued-product effects. Service revenue declined 4% to $24.6 million.
- Profitability: Gross margin increased, partly because 3M FSD products carried higher margins than Neogen’s legacy average. Operating income improved, but net income declined as acquisition-related debt interest and acquired-intangible amortization weighed on earnings. Interest expense was $18.5 million versus $0.002 million in the prior-year quarter; amortization expense was $23.7 million versus $2.4 million.
- Non-GAAP measures: Adjusted EBITDA was $52.4 million, with a 22.9% margin, versus $27.0 million and 20.4%. Adjusted EPS was $0.11 versus $0.16. These company-defined measures are not GAAP substitutes and may not be comparable with similarly titled measures from other companies.
- Cash flow and liquidity: Cash and cash equivalents were $178.8 million and marketable securities were $60.4 million at August 31, for combined liquidity of $239.3 million, compared with $245.6 million at May 31. Operating cash flow was positive; investing cash outflow was $8.7 million, including $30.6 million of property, equipment, and other non-current intangible purchases. Cash increased by $15.6 million during the quarter.
- Debt: Principal debt comprised a $550 million term loan and $350 million of 8.625% senior notes due 2030; the $150 million revolving facility remained undrawn. The term loan’s interest rate ranged from 7.45% to 7.67% during the quarter; a $250 million portion was hedged with an interest-rate swap. The company reported covenant compliance. Balance-sheet non-current debt, net of issuance costs, was $886.2 million.
Changes, outlook, and risks
- The 3M FSD acquisition added substantial revenue, assets, debt, and amortization. The prior-year quarter included $13.7 million of FSD transaction costs; the current quarter included $2.0 million of transaction and integration costs.
- Management provided no forecast of future financial performance. It expected to spend approximately $40–50 million purchasing remaining FSD inventory from 3M during fiscal 2024 and approximately $130 million on fiscal 2024 capital expenditures, including about $100 million for a new building, systems implementation, and food-safety integration projects.
- Transition invoicing and distribution services from 3M were expected to conclude by March 1, 2024; Neogen planned to begin manufacturing certain FSD products. Management cited softening consumer demand, high interest rates, inflation, geopolitical tensions, supply-chain and raw-material risks, and weaker demand in parts of Asia Pacific, particularly China. Two large domestic customers’ attrition reduced genomics service sales.
- Disclosure controls and procedures were deemed ineffective because of previously identified material weaknesses involving IT access and change-management controls, period-end invoice accruals, and management review of acquisition accounting and goodwill. Remediation was ongoing; management said the weaknesses would not be considered remediated until controls operated effectively for a sufficient period and were tested.
- The company reported a $916,000 environmental remediation liability for its Wisconsin facility; alternative remediation approaches could increase future costs. The OFAC investigation concerning transactions involving Iran was concluded without penalty, and the prior $600,000 accrual had been reversed in fiscal 2023. Management said other ordinary-course proceedings were not expected to have a material effect.
Important facts for investors to verify
- How much of reported Food Safety growth and margin performance is sustainable after separating 3M FSD and other acquisition effects from legacy core sales.
- Whether the planned FSD inventory purchases, manufacturing transition, and integration investments proceed on schedule and within expected costs.
- Debt-service capacity and exposure to variable interest rates, including the impact of the unhedged term-loan balance.
- Progress in remediating the disclosed internal-control material weaknesses and any subsequent changes in control effectiveness.
- Whether demand, supply-chain, inflation, currency, and geopolitical pressures—and potential environmental remediation changes—affect results or liquidity beyond management’s current expectations.